glp-1 and nerve pain Advances in receptor agonists for treatment their future potential | The Journal of Headache and Pain GLP-1 Drugs and Vision Loss:

In addition to functional analysis, the mitochondrial DNA copy number was measured via quantitative PCR to determine mitochondrial biogenesis

It also lists compounded tirzepatide separately as acting on both GLP-1 and GIP receptors

These changes are manageable with routine TSH monitoring every 6-8 weeks during initial semaglutide treatment

doi: 10.1111/dom.12352

Researchers are studying how they impact a range of different health issues including (but not limited to): Sleep apnea Metabolic disorders Neurodegenerative disorders Substance use disorders Liver disease Arthritis Inflammatory bowel disease Completing research studies and gaining FDA approval for new use cases takes time, but it looks likely that GLP-1s could be prescribed as treatment for a growing list of health issues in the coming years

Some alternatives position themselves as "luxury blends" with inflated pricing but no refund guarantee